Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Flecainide monotherapy is an option for selected patients with catecholaminergic polymorphic ventricular tachycardia intolerant of β-blockade.

× No keyword cloud information.

11 in total

1. The Role of Flecainide in the Management of Catecholaminergic Polymorphic Ventricular Tachycardia.

Authors: Krystien Vv Lieve; Arthur A Wilde; Christian van der Werf
Journal: Arrhythm Electrophysiol Rev Date: 2016-05

2. The Safety and Effectiveness of Flecainide in Children in the Current Era.

Authors: Taylor Cunningham; Orhan Uzun; Rachel Morris; Sonia Franciosi; Amos Wong; Ida Jeremiasen; Elizabeth Sherwin; Shubhayan Sanatani
Journal: Pediatr Cardiol Date: 2017-08-24 Impact factor: 1.655

3. Efficacy of Flecainide in the Treatment of Catecholaminergic Polymorphic Ventricular Tachycardia: A Randomized Clinical Trial.

Authors: Prince J Kannankeril; Jeremy P Moore; Marina Cerrone; Silvia G Priori; Naomi J Kertesz; Pamela S Ro; Anjan S Batra; Elizabeth S Kaufman; David L Fairbrother; Elizabeth V Saarel; Susan P Etheridge; Ronald J Kanter; Michael P Carboni; Matthew V Dzurik; Darlene Fountain; Heidi Chen; E Wesley Ely; Dan M Roden; Bjorn C Knollmann
Journal: JAMA Cardiol Date: 2017-07-01 Impact factor: 14.676

Review 4. Pregnancy in catecholaminergic polymorphic ventricular tachycardia: therapeutic optimization and multidisciplinary care are key to success.

Authors: Thomas M Roston; Jasmine Grewal; Andrew D Krahn
Journal: Herzschrittmacherther Elektrophysiol Date: 2021-04-21

5. Advancements in the use of gene therapy for cardiac arrhythmia.

Authors: Nathaniel P Murphy; Ellen R Lubbers; Peter J Mohler
Journal: Heart Rhythm Date: 2017-04-04 Impact factor: 6.343

Review 6. Multiple targets for flecainide action: implications for cardiac arrhythmogenesis.

Authors: Samantha C Salvage; Karthik H Chandrasekharan; Kamalan Jeevaratnam; Angela F Dulhunty; Andrew J Thompson; Antony P Jackson; Christopher L-H Huang
Journal: Br J Pharmacol Date: 2017-05-12 Impact factor: 8.739

7. Effect of flecainide derivatives on sarcoplasmic reticulum calcium release suggests a lack of direct action on the cardiac ryanodine receptor.

Authors: Mark L Bannister; Anita Alvarez-Laviada; N Lowri Thomas; Sammy A Mason; Sharon Coleman; Christo L du Plessis; Abbygail T Moran; David Neill-Hall; Hasnah Osman; Mark C Bagley; Kenneth T MacLeod; Christopher H George; Alan J Williams
Journal: Br J Pharmacol Date: 2016-06-29 Impact factor: 8.739

8. Safety and efficacy of flecainide for patients with catecholaminergic polymorphic ventricular tachycardia: A systematic review and meta-analysis.

Authors: Guangqiang Wang; Na Zhao; Shu Zhong; Yingrong Wang; Jianping Li
Journal: Medicine (Baltimore) Date: 2019-08 Impact factor: 1.817

9. Cardiac arrest in a mother and daughter and the identification of a novel RYR2 variant, predisposing to low penetrant catecholaminergic polymorphic ventricular tachycardia in a four-generation Canadian family.

Authors: Matthew Tung; Filip Van Petegem; Samantha Lauson; Ashley Collier; Kathy Hodgkinson; Bridget Fernandez; Sean Connors; Rick Leather; Shubhayan Sanatani; Laura Arbour
Journal: Mol Genet Genomic Med Date: 2020-01-28 Impact factor: 2.183

10. Flecainide Paradoxically Activates Cardiac Ryanodine Receptor Channels under Low Activity Conditions: A Potential Pro-Arrhythmic Action.

Authors: Samantha C Salvage; Esther M Gallant; James A Fraser; Christopher L-H Huang; Angela F Dulhunty
Journal: Cells Date: 2021-08-16 Impact factor: 6.600